According to a recent LinkedIn post from Resolution Therapeutics, the company’s team participated extensively in the Advanced Therapies conference in London. The post highlights presentations on regenerative macrophage therapy for inflammatory and fibrotic diseases, as well as chemistry, manufacturing and control (CMC) considerations for advanced therapy medicinal products.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post also notes involvement in discussions on cell therapy manufacturing, including AI, automation and digitalization, alongside sessions on supply chain and logistics. For investors, this visible technical and thought-leadership presence may signal ongoing investment in platform development, manufacturing capabilities, and geographic strategy across the EU, U.K., U.S., Australia and China, potentially supporting future partnering or fundraising activity.